Inception Sciences

Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.

Founded in 2011, Inception Sciences is a small molecule pharmaceutical incubator. Their focus is creating high-value therapies with transformative potential to address diseases and disorders with significant unmet need. Through partnerships with academic experts, they are translating biological insights into highly-targeted, novel drugs. Their team has a proven track record of drug discovery, having played pivotal roles in the discovery of clinical-stage compounds for the treatment of fibrosis, asthma and COPD at Amira Pharmaceuticals, and of several high-profile drugs at Merck.